Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Commensal bacteria calibrate the activation threshold of innate antiviral immunity.

Abt MC, Osborne LC, Monticelli LA, Doering TA, Alenghat T, Sonnenberg GF, Paley MA, Antenus M, Williams KL, Erikson J, Wherry EJ, Artis D.

Immunity. 2012 Jul 27;37(1):158-70. doi: 10.1016/j.immuni.2012.04.011. Epub 2012 Jun 14.

2.

Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection.

Xu HC, Huang J, Khairnar V, Duhan V, Pandyra AA, Grusdat M, Shinde P, McIlwain DR, Maney SK, Gommerman J, Löhning M, Ohashi PS, Mak TW, Pieper K, Sic H, Speletas M, Eibel H, Ware CF, Tumanov AV, Kruglov AA, Nedospasov SA, Häussinger D, Recher M, Lang KS, Lang PA.

J Virol. 2015 May;89(9):4748-59. doi: 10.1128/JVI.02976-14. Epub 2015 Feb 11.

3.
4.

Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A.

J Exp Med. 2009 Jan 16;206(1):79-87. doi: 10.1084/jem.20081667. Epub 2009 Jan 12.

5.
6.

Type I Interferon Induced Epigenetic Regulation of Macrophages Suppresses Innate and Adaptive Immunity in Acute Respiratory Viral Infection.

Kroetz DN, Allen RM, Schaller MA, Cavallaro C, Ito T, Kunkel SL.

PLoS Pathog. 2015 Dec 28;11(12):e1005338. doi: 10.1371/journal.ppat.1005338. eCollection 2015 Dec.

7.

Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.

Zhou S, Cerny AM, Fitzgerald KA, Kurt-Jones EA, Finberg RW.

J Virol. 2012 Oct;86(20):11254-65. Epub 2012 Aug 8.

8.

Confounding roles for type I interferons during bacterial and viral pathogenesis.

Carrero JA.

Int Immunol. 2013 Dec;25(12):663-9. doi: 10.1093/intimm/dxt050. Epub 2013 Oct 24. Review.

9.

Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract.

Marois I, Cloutier A, Garneau É, Richter MV.

J Leukoc Biol. 2012 Jul;92(1):107-21. doi: 10.1189/jlb.1011490. Epub 2012 Apr 13.

PMID:
22504848
10.

Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.

Anghelina D, Lam E, Falck-Pedersen E.

J Virol. 2016 Jun 10;90(13):5915-27. doi: 10.1128/JVI.00500-16. Print 2016 Jul 1.

11.

CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.

Suarez-Ramirez JE, Tarrio ML, Kim K, Demers DA, Biron CA.

MBio. 2014 Oct 21;5(5):e01978-14. doi: 10.1128/mBio.01978-14.

12.

Therapeutic depletion of natural killer cells controls persistent infection.

Waggoner SN, Daniels KA, Welsh RM.

J Virol. 2014 Feb;88(4):1953-60. doi: 10.1128/JVI.03002-13. Epub 2013 Nov 27.

13.

CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.

Lee YT, Ko EJ, Lee Y, Lee YN, Bian Z, Liu Y, Kang SM.

J Virol. 2016 Jul 11;90(15):6746-58. doi: 10.1128/JVI.00605-16. Print 2016 Aug 1.

14.

Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection.

Srivastava S, Koch MA, Pepper M, Campbell DJ.

J Exp Med. 2014 May 5;211(5):961-74. doi: 10.1084/jem.20131556. Epub 2014 Apr 7.

15.

Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.

Kulkarni RR, Rasheed MA, Bhaumik SK, Ranjan P, Cao W, Davis C, Marisetti K, Thomas S, Gangappa S, Sambhara S, Murali-Krishna K.

J Virol. 2014 Dec;88(24):13990-4001. doi: 10.1128/JVI.02273-14. Epub 2014 Sep 24.

16.

Role of ICOS versus CD28 in antiviral immunity.

Bertram EM, Tafuri A, Shahinian A, Chan VS, Hunziker L, Recher M, Ohashi PS, Mak TW, Watts TH.

Eur J Immunol. 2002 Dec;32(12):3376-85.

17.

Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.

Tlaskalová-Hogenová H, Stepánková R, Hudcovic T, Tucková L, Cukrowska B, Lodinová-Zádníková R, Kozáková H, Rossmann P, Bártová J, Sokol D, Funda DP, Borovská D, Reháková Z, Sinkora J, Hofman J, Drastich P, Kokesová A.

Immunol Lett. 2004 May 15;93(2-3):97-108. Review.

PMID:
15158604
18.

Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity.

McAfee MS, Huynh TP, Johnson JL, Jacobs BL, Blattman JN.

Virology. 2015 Oct;484:153-62. doi: 10.1016/j.virol.2015.05.021. Epub 2015 Jun 20.

19.

CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.

Teng O, Chen ST, Hsu TL, Sia SF, Cole S, Valkenburg SA, Hsu TY, Zheng JT, Tu W, Bruzzone R, Peiris JS, Hsieh SL, Yen HL.

J Virol. 2016 Dec 16;91(1). pii: e01813-16. Print 2017 Jan 1.

20.

Innate immunity to influenza virus infection.

Iwasaki A, Pillai PS.

Nat Rev Immunol. 2014 May;14(5):315-28. doi: 10.1038/nri3665. Review.

Supplemental Content

Support Center